ESC 365 - Apixaban 2.5 mg twice daily is effective and safe for patients with atrial fibrillation and combinations of advanced age, low body weight, and elevated creatinine: insights from ARISTOTLE

ESC Premium Access

Apixaban 2.5 mg twice daily is effective and safe for patients with atrial fibrillation and combinations of advanced age, low body weight, and elevated creatinine: insights from ARISTOTLE

Session: Poster Session 5 - Atrial fibrillation and oral anticoagulation 1

Topic: Oral Anticoagulation

Speaker: Doctor M. Zeitouni (Paris, FR)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Michel Zeitouni

Pitie Salpetriere APHP University Hospital, Paris (France)

0 follower

13 more presentations in this session

Oral anticoagulants and their effect on kidneys function, is warfarin safe?

Speaker: Associate Professor T. Novikova (Saint Petersburg, RU)

Evaluation of the HAS-BLED, ATRIA and ORBIT bleeding risk scores in newly diagnosed non-valvular atrial fibrillation.

Speaker: Doctor L. Bergamaschi (Bologna, IT)

Inappropriate dosing of non-vitamin K oral anticoagulants (NOACs) in atrial fibrillation patients in Europe

Speaker: Ms I. Palau (London, GB)

Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis

Speaker: Doctor Y. Gue (Liverpool, GB)

Concomitant oral anticoagulant and antidepressant therapy in patients with atrial fibrillation and risk of stroke and bleeding: a population based cohort study

Speaker: Professor P. Hjemdahl (Stockholm, SE)

Access the full session

Poster Session 5 - Atrial fibrillation and oral anticoagulation 1

Speakers: Doctor M. Zeitouni, Associate Professor T. Novikova, Doctor L. Bergamaschi, Ms I. Palau, Doctor Y. Gue...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources